Yes. Sharp Health Plan confirmed its participation in Medicare Advantage reporting after the final MY 2017 VBP4P was published on December 1, 2017. The final PO Master will reflect its Medicare Advantage contracts for reporting.
FAQ Directory
Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can ask a question through My NCQA.
Filter Results
-
Save
Save your favorite pages and receive notifications whenever they’re updated.
You will be prompted to log in to your NCQA account.
Save your favorite pages and receive notifications whenever they’re updated.
You will be prompted to log in to your NCQA account.
-
Email
Share this page with a friend or colleague by Email.
We do not share your information with third parties.
Share this page with a friend or colleague by Email.
We do not share your information with third parties.
-
Print
Print this page.
Print this page.
1.12.2018 MA- Medicare Advantage Plans Sharp Health Plan is included in the MY 2017 VBP4P clinical data file layouts posted on iha.org, but was not included in the final MY 2017 VBP4P Manual as a Medicare Advantage participating plan. Is Sharp Health Plan reporting for MA in MY 2017?
12.15.2017 Unhealthy Alcohol Use Screening and Follow-Up In the HEDIS 2018 Volume 2 Technical Update memo, the updated measure specification for Unhealthy Alcohol Use Screening and Follow-Up (ASF) now indicates there are three strata, but the specifications still note there are four. Which is correct?
There are three strata. The text should be revised in the following two places:
- Page 43, under “Single-Question (Positive) Response,” bullet 1 should reference “Males (Male AdministrativeGender Value Set) in Strata 1–2”; bullet 3 should reference “All members in Stratum 3.”
- Page 44, “Single-Question (Negative) Response,” bullet 1 should reference “Males (Male AdministrativeGender Value Set) in Strata 1–2 and bullet 3 should reference “All adults in Stratum 3.”
This applies to the following Programs and Years:
HEDIS 201812.15.2017 Reporting Requirements Last year, NCQA added the IS 3.1 standard in the Roadmap, stipulating that if a facility is mapped to a provider type, all providers at the facility must be of that provider type. Clarify this standard and whether a majority-mapping should be allowed this year. If so, at what level should it be enforced? Should a percentage of providers on the facility roster be of the mapped type, or is it preferable to review for whether a certain percentage of sampled services on claims be those typically received with the provider type? Should all mapped facilities be investigated individually, or is it acceptable to review the two or three with the highest volume?
For HEDIS reporting, NCQA does not allow blanket mapping a facility to a provider type, unless all providers who render services at the facility meet requirements for the provider type.
For HEDIS measures with a provider-type requirement, the information must be present for the service to be counted. For a facility to be mapped to a PCP (or another provider type) the organization must provide evidence that everyone at the facility meets the provider type requirement.
NCQA does not have an acceptable threshold allowance for auditors to audit against. Each facility must be reviewed individually. The auditor determines the impact of each facility's data on measures that require a particular provider type. From there, the auditor must review, with a level of certainty, who practices at the facility, the services they are contracted to perform and the potential impact to measures if an unacceptable provider renders a service that might count for a measure.
This applies to the following Programs and Years:
HEDIS 201812.15.2017 Transitions of Care The HEDIS 2018 Volume 2 Technical Update states that documenting preadmission exams and communicating planned admissions are not limited to the time frame criteria as other evidence for the Notification of Inpatient Admission indicator. Are there time frames that must be met?
No. There are no additional time frame requirements for preadmission exams or communicating about planned admissions, other than what is documented in the measure specifications. For example, it may meet the standard time frame (on the day of admission or the following day) or it may occur earlier. To prevent information from "different discharges" from being counted, the measure requires that it "must clearly pertain to the denominator event."
This applies to the following Programs and Years:
HEDIS 201812.15.2017 Controlling High Blood Pressure When confirming a hypertension diagnosis, a code from the Essential Hypertension Value Set can be used. This value set includes only ICD-10 codes. May ICD-9 codes be used to confirm the diagnosis?
Yes. Organizations may look back any time during a member’s history to confirm the diagnosis (including when ICD-9 codes were in use). Documentation of ICD-9 diagnosis codes 401.0, 401.1 or 401.9 may also confirm a diagnosis of hypertension.
This applies to the following Programs and Years:
HEDIS 2018
11.15.2017
Transitions of Care The HEDIS 2018 Volume 2 Technical Update memo indicates the following change in the Transitions of Care specifications: In the first sentence of the third paragraph, replace “date/time” with “date.”
Should this change also apply to the first bullet in the “Note” section of the technical specifications that reads, “The following notations or examples of documentation do not count as numerator compliant:
*Documentation of notification that does not include a time frame or date/time stamp.”
11.15.2017
Hospitalization for Potentially Preventable Complications On Page 37 of the HEDIS 2018 Volume 2 Technical Update memo, the “Number of Chronic ACSC Non-Outliers and Acute ACSC Non-Outliers” and “Number of Chronic ACSC Outliers and Acute ACSC Outliers” reporting categories have the same description.
Should the first reporting category listed above state ‘non-outlier’ instead of ‘outlier’?
Yes; the specifications should read “Reporting: Number of Chronic ACSC Non-Outliers and Acute ACSC Non-Outliers:The number of chronic ACSC non-outlier members and the number of acute ACSC non-outliers for each age and gender group and the overall total.”
This applies to the following Programs and Years:
HEDIS 201811.15.2017 Weeks of Pregnancy at Time of Enrollment The HEDIS 2018 Volume 2 Technical Update memo includes a RAND number for the “Weeks of Pregnancy at Time of Enrollment” measure. Is this correct?
11.15.2017 Guidelines for Calculations and Sampling The footnote on page 45 of HEDIS 2018 Volume 2 indicates that the lowest Prior Year rate from “Prenatal and Postpartum Care” and “Frequency of Prenatal Care” should be used to reduce the sample size for PPC. Given that FPC was retired with the HEDIS 2018 Volume 2 Technical Update, should the PPC MRSS use the lower rate of the Postpartum and Prenatal care indicators?
Yes. With the retirement of the FPC measure, organizations may reduce the sample size for the PPC measure using the lowest rate of the 2 indicators from the current year’s administrative rate or the prior year’s audited, product line-specific rate.
This applies to the following Programs and Years:
HEDIS 201811.15.2017 Supplemental Data Is it acceptable to flag records in a supplemental data file as paid or denied when there is no payment attached to the records in the file?
No. It is not acceptable to classify a supplemental data source as paid or denied unless it is known whether the data in the data source were paid or denied. This is especially true when the data are being used for measures that require claims payment statuses (e.g. LBP, NCS). Organizations should not assume services were denied services just because there isn't a payment status associated with them. For measures where payment status is required, the auditor must be able to validate that the payment status is accurate.
This applies to the following Programs and Years:
HEDIS 201811.15.2017 Reporting Requirements The HEDIS 2018 Volume 2 Technical Update memo announced the retirement of “Annual Monitoring for Patients on Persistent Medications (MPM)” for Medicare and the name change from “Inpatient Hospital Utilization (IHU)” to “Acute Hospital Utilization (AHU).” This caused a discrepancy between the CMS Reporting Memo and HEDIS 2018 Volume 2 Technical Specifications. Will CMS release a clarification on what must be reported for HEDIS 2018 for Medicare?
Yes. CMS released a clarification on October 11, 2017, through HPMS, announcing that MPM was retired and is not required for HEDIS 2018 reporting; it also clarified that “Inpatient Hospital Utilization” is now “Acute Hospital Utilization” and should be reported as the updated measure. If you have additional questions, contact CMS at HEDISquestions@cms.hhs.gov.
This applies to the following Programs and Years:
HEDIS 201811.15.2017 Use of Opioids at High Dosage In the HEDIS 2018 Volume 2 Technical Update memo Table UOD-A includes a variable ranging from 4-12 for the MED Conversion Factor for methadone based on mg/day of methadone used. However, in the HEDIS 2018 NDC MLD Directory all NDCs for Methadone under the medication list "Opioid Medication" have a MED Conversion Factor (column M) of 3. For performing the MED calculation in UOD, which MED Conversion Factor should be used for methadone?
For HEDIS 2018 reporting, for methadone, the MED conversion factor of "3" should be used as listed in the NDC list; not the factors listed in Table UOD-A. We will reevaluate using the sliding scale conversion factors for HEDIS 2019.